https://jamanetwork.com/journals/jamainternalmedicine/articl...
> The findings of this meta-analysis suggest that colorectal cancer screening with sigmoidoscopy may extend life by approximately 3 months; lifetime gain for other screening tests appears to be unlikely or uncertain.
I am neither a physician nor qualified to comment on the article itself, but remember reading an MD commenting on it last year saying efficacy of screening was better in the 80s-90s, but with contemporary cancer medicine and improvements in surgery, we can now treat bigger cancers so early screening doesn’t necessarily prolong life expectancy.
I would not take medical advice from myself or that article though. But to your comment, I doubt it’s only prostate cancer where early screening and treatment might not yield any returns
For a rare disease, I have already met too many people who have/had it. Lifetime risk is about 1:100 for white Europeans, not exactly commonplace, but not that rare either. I definitely don't ignore anything that happens on my skin, that would be a stupid way to die.
This is a reason I've read evidence based medicine people use for arguing against routine whole-body imaging.
As it says the average age of men getting it is 67. From experience and from data I had seen, a lot of times, the surgeons simply believe the patient is too old to have any surgery. And when they die -- e.g. family I had -- they note down the cause of death as natural causes. When you are 80-90+, practically everything gets written as natural causes.
Finally, with prostate cancer, from what we know it is not a question if a man will have prostate cancer but if the man will die before prostate cancer becomes serious or appears. That is if we doubled the age of survival to 200 years I think we would expect virtually every male at that age to have gone through prostate cancer.